The Core?s mission is to foster career development of HIV investigators and leaders. We have successfully done this with an 885% return on investment (RoI) over the past decade for our major awards (New Investigator Awards [NIAs]). In this proposal, we propose to double this Core?s budget (to 25% of CFAR?s NIH funding plus substantial additional committed institutional funds) to enhance support for the next generation of HIV Early Stage Investigators (ESIs). We will continue existing, high value activities and propose to enhance the work of this Core through an innovative new award program, new leveraging of institutional opportunities, increasing support for fostering diversity, and additional mentoring opportunities. Lastly, we will integrate the awards previously coordinated by our International Core to support UW/Fred Hutch CFAR members in resource limited settings (RLS). Our mission is articulated via four Specific Aims as follows:
AIM 1. To create and nurture a cadre of innovative, interdisciplinary HIV researchers by providing research and focused career support to affiliated ESIs. Activities: NIAs, enhanced career support for NIA recipients, Trainee Support Grants (TSGs), administrative support for NIH supplements, and advocacy and support for NIH Diversity Supplements among CFAR members.
AIM 2. To foster innovative research to enhance use of existing CFAR resources with a new type of award and provide research and infrastructure support to CFAR's international investigators. Activities: Investment of Catalytic Funds to Access Resources (iCFAR) Awards, International Pilot Awards, Localizing Global Research Awards, International Infrastructure Awards, and Mentored International Investigator Awards.
AIM 3. To enhance communication skills for early to mid-stage HIV investigators at CFAR-affiliated institutions and use of research educational opportunities across the CFAR. Activities: manuscript and grant workshops conducted in Seattle and 3 partner countries; leveraging existing career development opportunities at UW, Fred Hutch, and other partner institutions; an annual Mock Study Section and an annual CFAR research symposium, that includes a Junior Investigator Poster Session.
AIM 4. To advance and sustain skills of CFAR-affiliated mentors and provide mentoring consultation. Activities: annual mentor-the-mentor workshop; collaborating with the UCSF CFAR to share mentoring resources; matching ESIs to mentors, and consultation for challenging mentor-mentee situations. The Core?s Steering Committee oversees the Core?s activities and participates actively in award review processes. Each activity is assessed annually for value and prioritized or modified as appropriate. The Core supports development of expertise and skills so CFAR investigators can perform high priority, high-impact, innovative, multidisciplinary research to address the global HIV epidemic and develop leadership skills.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-33
Application #
9947861
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
33
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
Ronen, Keshet; Unger, Jennifer A; Drake, Alison L et al. (2018) SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content. AIDS Care 30:500-505
Njuguna, Irene N; Wagner, Anjuli D; Omondi, Vincent O et al. (2018) Financial Incentives for Pediatric HIV Testing in Kenya. Pediatr Infect Dis J 37:1142-1144
Stone, Mars; Bainbridge, John; Sanchez, Ana M et al. (2018) Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates. J Clin Microbiol 56:
Herbeck, Joshua T; Peebles, Kathryn; Edlefsen, Paul T et al. (2018) HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. Vaccine 36:514-520
Roberts, Sarah T; Flaherty, Brian P; Deya, Ruth et al. (2018) Patterns of Gender-Based Violence and Associations with Mental Health and HIV Risk Behavior Among Female Sex Workers in Mombasa, Kenya: A Latent Class Analysis. AIDS Behav 22:3273-3286
Duarte, Horacio A; Beck, Ingrid A; Levine, Molly et al. (2018) Implementation of a point mutation assay for HIV drug resistance testing in Kenya. AIDS 32:2301-2308
Mugwanya, Kenneth K; Baeten, Jared M; Wyatt, Christina et al. (2018) Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr 77:206-211

Showing the most recent 10 out of 1275 publications